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Tyrosine phosphorylation of cytoskeletal proteins occurs during integrin-mediated cell
adhesion to extracellular matrix proteins. We have investigated the role of tyrosine phos-
phorylation in the migration and initial spreading of human umbilical vein endothelial
cells (HUVEC). Elevated phosphotyrosine concentrations were noted in the focal adhesions
of HUVEC migrating into wounds. Anti-phosphotyrosine Western blots of extracts of
wounded HUVEC monolayers demonstrated increased phosphorylation at 120-130 kDa
when compared with extracts of intact monolayers. The pp125FAK immunoprecipitated
from wounded monolayers exhibited increased kinase activity as compared to ppl25FAK
from intact monolayers. The time to wound closure in HUVEC monolayers was doubled
by tyrphostin AG 213 treatment. The same concentration of AG 213 interfered with HUVEC
focal adhesion and stress fiber formation. AG 213 inhibited adhesion-associated tyrosine
phosphorylation of pp125FAK in HUVEC. Tyrphostins AG 213 and AG 808 inhibited
pp125FAK activity in in vitro kinase assays. pp125FAK immunoprecipitates from HUVEC
treated with both of these inhibitors also had kinase activity in vitro that was below levels
seen in untreated HUVEC. These findings suggest that tyrosine phosphorylation of cyto-
skeletal proteins may be important in HUVEC spreading and migration and that pp125FAK
may mediate phosphotyrosine formation during these processes.
INTRODUCTION
The extracellular matrix influences many aspects of cell
behavior. Recently, much attention has focused on the
signaling pathways that are associated with integrin
binding to extracellular matrix ligands (Burridge et al.,
1992a; Hynes, 1992; Juliano and Haskill, 1993). An ele-
vation in tyrosine phosphorylation has been observed
in response to both integrin clustering (Komberg et al.,
1991) and integrin-mediated cell adhesion (Guan et al.,
1991; Burridge et al., 1992b). One of the proteins that
is phosphorylated on tyrosine during integrin-mediated
cell adhesion is ppl25 AK (Burridge et al., 1992b; Guan
and Shalloway, 1992; Hanks et al., 1992; Komberg et
al., 1992; Lipfert et al., 1992). pp125FAK is a tyrosine
kinase that has been localized to focal adhesions in fi-
broblasts (Hanks et al., 1992; Schaller et al., 1992) and
that may serve an important role in signal transduction
during cell interactions with extracellular matrix, neu-
ropeptides, and oncogenes (Zachary et al., 1992; Zachary
and Rozengurt, 1992). The adhesion-associated increase
in pp125FAK tyrosine phosphorylation has been shown
to correlate with increased tyrosine kinase activity (Guan
and Shalloway, 1992; Lipfert et al., 1992).
In vascular endothelium, interactions with extracel-
lular matrix result in changes in cell morphology,
growth, and motility (Young and Herman, 1985; Kubota
et al., 1988; Madri et al., 1988; Ingber and Folkman,
1989; Yost and Herman, 1990). The integrin family of
adhesion receptors is directly involved in endothelial
cell binding to a variety of extracellular matrix proteins
and may modulate phenotypic changes associated with
inflammation (Albelda et al., 1989; Albelda and Buck,
1990; Defilippi et al., 1992). The complex sheet migra-
tion response of endothelial cells to mechanical wound-
ing in vitro involves cell spreading and migration on an
extracellular matrix, as well as cell proliferation (Coom-
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ber and Gotlieb, 1990). Cytoskeletal mechanisms have
been implicated in regulating these processes (Gotlieb
et al., 1981; Wong and Gotlieb, 1984). We have inves-
tigated tyrosine phosphorylation events during the en-
dothelial cell wound healing response in an attempt to
elucidate signal transduction mechanisms that mediate
cell-extracellular matrix interactions.
We have found increased tyrosine phosphorylation
in the focal adhesions of migrating human umbilical
vein endothelial cells (HUVEC) adjacent to wounds.
pp125F" is one of the proteins demonstrating increased
tyrosine phosphorylation in wounded HUVEC mono-
layers and is concentrated in focal adhesions in these
cells. Tyrosine kinase inhibitor treatment of HUVEC re-
tards wound healing and inhibits cytoskeletal organi-
zation. The same inhibitors also affect pp125FAK tyrosine
phosphorylation and kinase activity. These findings
imply a role for pp125FAK-mediated tyrosine phos-
phorylation in focal adhesion assembly and in the en-
dothelial cell response to mechanical injury.
MATERIALS AND METHODS
Cell Culture, Monolayer Wounding, and Protein
Tyrosine Kinase Inhibitors
HUVEC were harvested from fresh human umbilical veins using
modifications of previously described techniques (Gimbrone et al.,
1974). Segments of vessels were cannulated, gently irrigated to remove
debris, and incubated with 1 mg/ml collagenase (Worthington Bio-
chemical, Freehold, NJ) for 10 min. The irrigant was then agitated
within the vessels and collected. Harvested cells were plated on tissue
culture plastic that had been preincubated with 1% gelatin (Difco,
Detroit, MI) in Dulbecco's phosphate-buffered saline (PBS). HUVEC
were cultured in medium 199 with Earle's salts, supplemented with
vitamins and amino acids (GIBCO BRL, Gaithersburg, MD), 20% fetal
calf serum, 100 Ag/ml heparin, - 100 ug/ml endothelial cell growth
factor isolated from bovine hypothalamus, 50 ,t/ml penicillin, 50 tg/
ml streptomycin, and 4 ,g/ml amphotericin B. HUVEC were used
between passages two and four. Cells were passaged 7 d before use.
Verification of HUVEC identity was accomplished by morphology
and by positive testing for von Willebrand's factor by immunofluo-
rescence microscopy with polyclonal antibody obtained from Sigma
Chemical (St. Louis, MO).
For wounding experiments and gel and blot analysis, cells were
plated at - 6 X 104 cells/cm2. Coverslips or culture dishes were coated
with human plasma fibronectin (New York Blood Center, NY) (75
jig/ml) by incubation at 37°C for 60 min or in some experiments by
incubation overnight at 4°C. Before plating cells, coverslips or dishes
were rinsed twice in serum-free Dulbecco's modified Eagle's medium.
Single wounds were made in confluent monolayers by dragging a
sterile 1-mm pipette tip across the monolayer to create a cell-free
path. Multiple wounds were made by using a comb-like device fash-
ioned from soft nylon bristles cemented to a plastic frame. This device
was sterilized for each use. For multiple wounding experiments,
monolayers were cultured in the absence of endothelial cell growth
factor and heparin for 72 h before wounding and were allowed to
recover for 96 h after wounding, before harvest for blot and immu-
noprecipitation analysis. These monolayers were not supplied with
fresh serum for 7 d before harvesting. For adhesion experiments, cells
were trypsinized, washed once in medium containing 10% serum,
washed once in serum-free medium, resuspended, and plated in
serum-free medium.
For some experiments, HUVEC were treated with various concen-
trations of tyrphostins AG 213 or AG 808 (generous gifts of Alexander
Levitski, The Hebrew University of Jerusalem) or of herbimycin A
(GIBCO BRL). Inhibitors were dissolved in dimethyl sulfoxide (DMSO)
before use in tissue culture medium. Cells were pretreated with in-
hibitors for 24 h before plating on fibronectin in the presence of the
same inhibitor at the same concentration. Confluent HUVEC mono-
layers were also pretreated with inhibitors for 24 h before wounding.
Recovery from tyrphostin effects was studied in monolayers incubated
in medium free of inhibitors for various times.
Fluorescence Microscopy
Cells were fixed in 3.7% formaldehyde in Dulbecco's PBS for 10 min,
rinsed in 150 mM NaCl, 0.1% NaN3, 50 mM tris(hydroxymethyl)-
aminomethane HCl pH 7.6 (TBS) and permeabilized for 5 min in TBS
containing 0.5% Triton X-100 before staining for immunofluorescence
microscopy. The coverslips were blocked with 4% horse serum (GIBCO
BRL) in TBS for 30 min at 37°C before incubations with antibodies.
Coverslips were then incubated for 30 min with py2O (ICN Biochem-
icals, Costa Mesa, CA) in TBS with 4% horse serum. The coverslips
were then rinsed extensively in TBS and then stained with fluorescein-
conjugated, affinity-purified goat anti-mouse IgG Uackson Immuno-
Research, West Grove, PA) for 30 min at 37°C. For visualization of
ppl25FAK, coverslips were incubated with antibody 2A7 (generous
gift of Drs. J. Thomas Parsons and Michael Schaller, University of
Virginia) (Schaller et al., 1992) and then stained with a second antibody
as described above. Other coverslips were incubated with py2O mixed
with affinity-purified rabbit anti-human talin and then stained with
a mixture of rhodamine-labeled, affinity-purified goat anti-mouse IgG
(Chemicon International, Temecula, CA) and fluorescein-labeled,
affinity-purified goat anti-rabbit IgG (Chemicon International) for 30
min at 37°C. For visualization of filamentous actin, coverslips were
incubated with rhodamine-conjugated phalloidin (Molecular Probes,
Eugene, OR) for 30 min at 37°C. After the antibody incubations, the
coverslips were washed in TBS, rinsed in deionized water, and
mounted with gelvatol or mowiol. Coverslips were viewed on a Zeiss
Axiophot microscope (Thornwood, NY) equipped for epifluorescence.
Fluorescence micrographs were taken on T-max 400 film (Eastman
Kodak, Rochester, NY).
Sodium Dodecyl Sulfate-Polyacrylamide Gel
Electrophoresis (SDS-PAGE) and Western
Blot Analysis
After several washes with serum-free medium and PBS, cells were
prepared for SDS gel electrophoresis of whole cell lysates by scraping
with a teflon policeman in 100 gl of Laemmli sample buffer containing
1 mM Na orthovanadate. The samples were boiled for 3 min, and
the DNA was sheared by passing several times through a 26 gauge
needle. Samples containing equal protein concentrations were elec-
trophoresed on 7.5% SDS-polyacrylamide gels (Laemmli, 1970) with
a bisacrylamide concentration of 0.19%. After electrophoresis, gels
were either stained with Coomassie blue or transferred to nitrocellulose
(Towbin et al., 1979). After blocking of the nitrocellulose, phospho-
tyrosine-containing proteins were visualized in some experiments by
incubation with '25I-labeled py2O ('-2 X 106 cpm/ml, ICN Biochem-
icals) for 60 min. After washing for 60 min, the nitrocellulose was
exposed with an intensifying screen to x-ray film for autoradiography.
Iodine- 125 was purchased from New England Nuclear (Wilmington,
DE), and py2O was radio-iodinated using iodogen (Pierce Chemical,
Rockford, IL) according to previously described protocols (Fraker and
Speck, 1978). Immunoprecipitates were subjected to blot analysis using
enhanced chemiluminescence (Amersham, Arlington Heights, IL) with
horseradish peroxidase (HRP)-conjugated py2O (ICN Biochemicals)
and techniques described previously (Bockholt et al., 1992). Nitro-
cellulose membranes that were analyzed by this technique were in-
cubated for 30 min with blocking buffer (TBS with 2.5% bovine serum
albumin [BSA] and 0.05% Tween 20) before the antibody incubation.
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Figure 1. Tyrosine phosphorylation
is increased in the focal adhesions of
migrating endothelial cells. Confluent
monolayers of HUVEC cultured on fi-
bronectin-coated glass coverslips were
wounded with a pipette tip and
stained for immunofluorescence mi-
croscopy with an anti-phosphotyro-
sine antibody. Coverslips were stained
at the time of wounding (0 h, A and
B), at 48 h (C and D), and 96 h (E and
F) after wounding. A, C, and E depict
cells adjacent to the wound, and B, D,
and F depict cells distant from the
wound breach in the quiescent portion
of the monolayer. Phosphotyrosine is
prominent in the focal adhesions of
the actively migrating cells in C but
barely detectable in quiescent cells
distant from the wound. The micro-
scopic field is centered over the






Cells were lysed by scraping in TBS containing 1 mM Na orthovan-
adate, 10 Mg/ml leupeptin, 0.1% Triton X-100, and 0.1% Na deoxy-
cholate, and the lysates were clarified by centrifugation at 100 000
X g for 30 min. Lysate volumes were normalized for equal protein
content using Coomassie blue-staining of sample aliquots subjected
to SDS-PAGE. pp125FAK was immunoprecipitated by incubating ly-
sates with antibody 2A7 at 4°C for a minimum of 90 min. Rabbit
anti-mouse IgG (ackson ImmunoResearch) bound to protein A seph-
arose was then added to these samples and incubated with end over
end mixing for a minimum of 90 min at 4°C. Beads were sedimented
by brief centrifugation and washed extensively with lysis buffer. Pro-
teins were then released for SDS-PAGE and blot analysis by boiling
in Laemmli sample buffer with 1 mM Na orthovanadate for 3 min.
In Vitro Kinase Activity Assays
pp125FAK that had been immunoprecipitated from cell lysates and
bound to protein A sepharose as above was washed with lysis buffer
and then with TBS before transfer to 3 mM MnCl2 with 10 mM pi-
perazine-N,N'-bis(2-ethanesulfonic acid) pH 7.46. The beads were
then incubated with 10 MCi per sample 32P-labelled -yATP (New
England Nuclear) at room temperature for 20 min to examine pp125F'
autophosphorylation. Samples were then boiled for 3 min with
Laemmli sample buffer containing 1 mM sodium orthovanadate and
subjected to SDS-PAGE on a 10% polyacrylamide gel with a bisa-
crylamide concentration of 0.13%. These gels were then stained with
Coomassie blue, dried, and exposed to x-ray film and an intensifying
screen at -70°C for autoradiography. Some gels were subjected to
alkaline hydrolysis with 1 N KOH at 55°C for 1 h before restaining
with Coomassie blue, drying, and autoradiography.
RESULTS
Tyrosine Phosphorylation in Migrating
Endothelial Cells
An in vitro model of endothelial cell response to me-
chanical wounding was used to study the pattern of
tyrosine phosphorylation in migrating endothelial cells.
Confluent monolayers of HUVEC cultured on fibro-
nectin-coated surfaces were wounded by scraping the
cells from the substratum with a pipette tip generating
an -1-mm cell-free path. The distribution of phos-
photyrosine in cells migrating into the wound breach
was then studied at various time intervals by immu-
nofluorescence microscopy, using the monoclonal an-
tibody py2O (Figure 1). To obtain comparable data from
all fields, photographic exposure and development times
were identical throughout. Phosphotyrosine was ele-
vated at the edge of the wound in cells that were actively
migrating into the cleared area (Figure 1C) (the direction
of migration is upward). This observation was noted in
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migrating cells as early as 6 h after wounding. The pat-
tern of staining was consistent with elevated tyrosine
phosphorylation in focal adhesions at the cell periphery.
The elevated phosphotyrosine-staining pattern was not
seen beyond three cells from the migrating cell front.
The remainder of the monolayer demonstrated low
background levels of phosphotyrosine staining even at
48 h after wounding, when the migration process was
at its peak. Confluent monolayers, both before and after
wounding (Figure 1, B and E, respectively), revealed
only a faint pattem of phosphotyrosine staining in focal
adhesions. These data are consistent with previous de-
scriptions of increased tyrosine phosphorylation in the
newly forming, peripherally located focal adhesions of
freshly plated fibroblasts (Burridge et al., 1992b).
The proteins containing increased phosphotyrosine
in actively migrating endothelhal cells were analyzed by
immunoblotting with 1251I-labeled py2O (Figure 2A).
Multiple wounds were made in HUVEC monolayers
with a comb-like device constructed from nylon bristles
so as to cause a maximal number of cells to be contig-
uous to wound margins. Both intact and wounded
monolayers were extracted 48-96 h after the wounds
were made. The predominant band on these anti-phos-
photyrosine autoradiographs was seen at - 120-130
kDa, and an increase in phosphotyrosine was noted in
this molecular weight range in the extract of the multiply
wounded monolayer as compared with that of the intact
control monolayer (Figure 2A). Immunoblot analysis of
lysates with enhanced chemiluminescence has not
yielded the detection of additional bands. The time
course and the ratio of wounded to intact surface area
of the monolayer were critical for these experiments,
because the increase in tyrosine phosphorylation present
in the migrating cell population was diluted by normal
phosphotyrosine levels in unaffected cells in large is-
lands of the intact monolayer surface. Western blots of
extracts of multiply wounded HUVEC monolayers that
had either very few wounds or less time to mobilize
cells revealed less phosphotyrosine activity. To achieve
a quiescent state, monolayers were harvested 7 d after
feeding the cells with fresh serum-containing medium.
Intact monolayers that had been more recently fed with
fresh serum-containing medium, endothelial cell growth
factor, and heparin exhibited higher levels of tyrosine
phosphorylation.
We considered the possibility that pp125FAK was one
of the proteins with an increase in tyrosine phosphor-
ylation during HUVEC migration. To determine
whether a change in pp125FAK expression accompanied
the response to wounding, whole cell lysates from intact
and wounded monolayers were immunoblotted with
anti-ppl25FAK antibody. Lysates were normalized for
protein concentration before loading on the gel. Equiv-
alent amounts of pp125FAK were found in both intact
and wounded monolayers (Figure 2B). pp125F"K was
immunoprecipitated from lysates with equal pp125FAK
A B C






Figure 2. Increased pp125F' kinase activity is observed in migrating
endothelial cells. Cell lysates of intact (lane 1) and multiply wounded
(lane 2) HUVEC monolayers cultured on fibronectin were electro-
phoresed on polyacrylamide gels, transferred to nitrocellulose, and
blotted with l5I-py2O (A). Protein loads had been normalized using
Coomassie blue-stained gels. Marker proteins (125I-labeled in the left
panel) are shown in the lane labeled M. The molecular masses of
marker proteins are indicated in kDa to the left of the autoradiograph.
Phosphotyrosine is increased in a cluster of dominant bands at 120-
130 kDa in the lysate from the wounded monolayer. An anti-pp125F'
immunoblot of whole cell lysates from intact (lane 1) and multiply
wounded (lane 2) HUVEC monolayers is shown in B. Equal amounts
of pp125FAK were found in the two cell populations. pp125FAK was
then immunoprecipitated from parallel lysates and used in in vitro
kinase assays with 32P-labeled 'yATP (C). Autophosphorylation was
used as an indicator of kinase activity and was increased in immu-
noprecipitates from multiply wounded monolayers (C, lane 2) as
compared with that of intact controls (C, lane 1).
content, and the immunoprecipitates were incubated
with 32p y-ATP to examine pp125FAK autophosphory-
lation (Figure 2C). Autophosphorylation of pp125FAK
was used as a measure of pp125FA kinase activity (Lip-
fert et al., 1992; Schaller et al., 1992). Increased pp125 AK
kinase activity was noted in the immunoprecipitates
from wounded monolayers as compared to those from
intact controls. This increase was quantified using scin-
tillation counting to determine the amount of 2P in-
corporated into the bands corresponding to ppl25FAK
that had been excised from the dried gel. A 72% increase
in 32p incorporation activity was seen in the band from
the multiply wounded monolayer as compared to that
from the intact control.
Immunofluorescence microscopy was then used to
study the pattern of pp125FAK distribution in migrating
and in freshly plated HUVEC (Figure 3, A and B, re-
spectively). To assess the migrating condition, confluent
HUVEC monolayers were established on fibronectin-
coated coverslips, and migration was induced by re-
moving the cells from one-half of the coverslip with a
teflon policeman. Twelve hours after wounding, mi-
grating cells were stained with the monoclonal antibody
2A7 (Figure 3A). Other HUVEC were plated on fibro-
nectin in serum-free conditions for 1 h (Figure 3B).
Staining for pp125FAK was localized to a focal adhesion
pattern in both migrating and spreading HUVEC. Focal
adhesions staining for ppl25F were seen in both the
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Figure 3. pp125FAK is localized to focal
adhesions in endothelial cells during mi-
gration and spreading. HUVEC plated on
fibronectin were wounded after growth
to confluence (A) or allowed to spread for
1 h in serum-free medium (B). Cells were
stained for immunofluorescence with
monoclonal anti-ppl25FAK antibody.
Staining in a pattern consistent with focal
adhesions is seen in both panels. The ar-
row indicates the direction of cell migra-
tion. Bar, 10 Am.
advancing lamellipodia and the trailing tails of migrating
cells (Figure 3A). Actively spreading HUVEC exhibited
the most prominent ppl2SFA staining in focal adhesions
near the cells' periphery (Figure 3B).
Tyrphostin Inhibition of Endothelial Cell Migration
To study the functional importance of the observed in-
crease in tyrosine phosphorylation in new focal adhe-
sions of actively migrating HUVEC, tyrphostins were
assayed for their effect on the rate of wound closure in
the wound healing model described above (Figure 4).
Tyrphostins were chosen because of their specific in-
hibition of tyrosine kinases and their low cytotoxicity
(Levitski, 1990). Confluent HUVEC monolayers on fi-
bronectin-coated surfaces were wounded with pipette
tips. Monolayers were untreated (Figure 4, A, C, and
E) or pretreated for 24 h with and maintained in the
presence of tyrphostin AG 213 (100 ,uM, solubilized in
DMSO) (Figure 4, B, D, and F) and stained with rho-
damine-conjugated phalloidin at various time points
after wounding. Tyrphostin was added to treated
monolayers on the day of wounding, and this treatment
was not augmented on subsequent days. The initial
wound breach measured - 1 mm in width (time 0, Fig-
ure 4, A and B). Untreated HUVEC had migrated into
the center of the wound breach by 48 h (Figure 4C).
During the same time period, tyrphostin-treated cells
had only migrated - 150 ,tm (Figure 4D). The center of
the wound breach in the tyrphostin-treated monolayer
is shown in Figure 4D, and a few migrating cells are
just seen at the edges. At 96 h, the untreated cells had
thoroughly covered all traces of the wound path,
whereas the leading cells of the tyrphostin-treated cul-
tures were just entering the central region of the wound
breach (Figure 4, E and F, respectively). Pretreatment
of monolayers with lower concentrations of AG 213
(25, 50, and 75 ,tM) produced partial and incremental
inhibition of HUVEC migration. Observations of
DMSO-treated HUVEC monolayers did not differ from
untreated controls. Herbimycin A (875 nM) and tyr-
phostin AG 808 (100 ,uM) also inhibited wound closure.
Within 48 h of tyrphostin treatment, a relative paucity
of stress fibers and focal adhesions was seen in migrating
HUVEC. After 96 h of incubation in the-presence of
tyrphostin, stress fibers were again seen in migrating
cells (Figure 4F). Twenty-four hours of tyrphostin pre-
treatment had no detectable effect on the stress fibers
seen in intact monolayers (Figure 4B).
Tyrphostin Inhibition of Focal Adhesion and Stress
Fiber Formation
Tyrphostin effects on focal adhesion formation and
stress fiber assembly were then studied in freshly plated
HUVEC (Figure 5). To avoid confounding effects of
growth factors and extracellular matrix proteins con-
tained in serum, HUVEC were plated on fibronectin for
1 h in medium free of serum (and without heparin and
growth factors), in the absence (Figure 5, A, C, and E)
or presence (Figure 5, B, D, and F) of tyrphostin AG
213 (100 ,um, solubilized in DMSO). HUVEC were pre-
treated with tyrphostin for some experiments. Cells were
stained for immunofluorescence microscopy with an-
tibodies against phosphotyrosine (Figure 5, A and B)
and talin (Figure 5, C and D), and with rhodamine-
conjugated phalloidin (Figure 5, E and F). Untreated
HUVEC revealed a well spread morphology with a well
defined focal adhesion pattern when stained with anti-
phosphotyrosine antibody. This correlated with the
pattern seen for talin (A and C). Many tyrphostin-
treated cells, however, were not well spread. Both
phosphotyrosine and talin staining were confined to a
rim of peripheral brightness, and a focal adhesion pat-
tern was not revealed (B and D). Phalloidin staining
demonstrated an array of well developed stress fibers
Vol. 5, March 1994 353
L.H. Romer et al.
Figure 4. Tyrphostin AG 213 inhibits endothelial cell wound healing. Untreated HUVEC monolayers (A, C, and E) and monolayers pretreated
with and maintained in the presence of 100 uM tyrphostin AG 213 (B, D, and F) were wounded with a pipette tip to generate a 1-mm strip
cleared of cells. Coverslips were stained with rhodamine-conjugated phalloidin to visualize cells at the time of wounding (A and B), at 48 h
(C and D), and at 96 h (E and F) after wounding. C-F were photographed in the center of the wound breach. Tyrphostin treatment delayed
the closure of the wound breach. Bar, 150 ,gm.
in untreated HUVEC that contrasted sharply with the
pattern of reduced stress fibers in the tyrphostin-treated
cells (Figure 5, E and F). HUVEC treated with 25 and
50 ,uM tyrphostin AG 213 demonstrated partial inhi-
bition of stress fiber assembly as compared with cells
treated with 100 ,gM AG 213. DMSO-treated cells re-
vealed staining patterns that were similar to those of
the untreated controls.
Inhibition of ppl25F'K Kinase Activity
Given the increased kinase activity of ppl25FAK in
wounded HUVEC monolayers shown in Figure 2, we
Molecular Biology of the Cell354
Tyrosine Phosphorylation and Endothelial Cell Migration
Figure 5. Tyrphostin inhibition of focal adhesion and stress fiber formation in HUVEC. Untreated HUVEC (A, C, and E) or HUVEC plated
in the presence of 100 MM tyrphostin AG 213 (B, D, and F) were plated in serum-free medium on fibronectin for 1 h. Cells were stained for
imnmunofluorescence with anti-phosphotyrosine antibodies (A and B), anti-talin antibodies (C and D), or with rhodamine-conjugated phalloidin
(E and F). Bar, 10 ,m.
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Figure 6. Tyrphostin AG 213 inhibits the adhesion-associated ty-
rosine phosphorylation of pp125FAK. (A) Anti-phosphotyrosine anti-
body was used to immunoblot pp125FAK immunoprecipitates from
HUVEC kept in suspension for 1 h (lane 1) or plated on fibronectin
for 1 h in the absence (lane 2) or presence (lane 3) of tyrphostin AG
213. Tyrphostin-treated HUVEC were preincubated with the inhibitor
for 24 h before plating. The adhesion-associated increase in phos-
phorylation on tyrosine in ppl25FAK was inhibited by AG 213. Mo-
lecular masses of marker proteins are indicated at the left of the imn-
munoblot. (B) An anti-pp125F4K immunoblot of pp125FAK immuno-
precipitates from HUVEC is shown. Cells were plated on fibronectin
in the absence (lane 1) or presence (lane 2) of tyrphostin AG 213.
Tyrphostin treatment has not altered pp125F" levels.
examined the effects of tyrphostin on pp125FAK phos-
phorylation (Figure 6a). pp125FAK was immunoprecip-
itated from HUVEC kept in suspension for 1 h (lane 1)
or plated on fibronectin for 1 h in the absence (lane 2)
or presence (lane 3) of tyrphostin AG 213 (100 ,M) and
then transferred to nitrocellulose and blotted with HRP-
conjugated py2O. Increased phosphorylation on tyrosine
was noted in the ppl25FA immunoprecipitated from
HUVEC that had adhered to fibronectin as compared
to that from cells kept in suspension (Figure 6a, lanes
1 and 2). This increase was inhibited in immunoprecip-
itates from HUVEC that had been plated on fibronectin
in the presence of AG 213 (Figure 6a, lane 3). Tyrphostin
pretreatment of HUVEC was not, however, associated
with alteration of pp125FAK levels (Figure 6b).
We then studied the direct effects of tyrosine kinase
inhibitors on isolated pp125F' kinase activity. For these
experiments ppl25FAKimmunoprecipitates from un-
treated HUVEC were incubated with 32P-labeled yATP
in the presence of tyrosine kinase inhibitors (Figure 7).
Untreated HUVEC were kept in suspension (lane 1) or
plated on fibronectin for 1 h in serum-free medium
(lanes 2-5). Isolated pp125F' immunoprecipitates were
untreated (lanes 1 and 2) or were treated with herbi-
mycin A (875 nM, lane 3), tyrphostin AG 213 (100,uM,
lane 4), or tyrphostin AG 808 (100,uM, lane 5). ppl25FAK
immunoprecipitated from HUVEC kept in suspension
showed decreased kinase activity as compared to the
pp125FAK from HUVEC that had adhered to fibronectin
(lanes 1 and 2). This observation was not altered when
the gel was incubated with 1 N KOH for 1 h at 55°C,
1 2 3 4 5 Figure 7. Effect of inhibitors on isolated
ppl25F kinase activity. pp125AF was im-
munoprecipitated and used in in vitro kinase
200 assays with 32P-labeled 'yATP. Autophos-
phorylation was used as an indicator of ki-
_____ nase activity. pp125FAK was immunoprecip-
116 itated from HUVEC that were either kept
97 in suspension for 1 h (lane 1) or plated for
1 h on fibronectin in serum-free medium
68 (lanes 2-5). Immunoprecipitates were either
untreated (lanes 1 and 2) or treated with
45 herbimycin A (875 nM, lane 3), tyrphostin
AG 213 (100 AM, lane 4), or tyrphostin AG
808 (100 AM, lane 5). Molecular masses of
marker proteins are indicated at the left of
- the autoradiograph.
indicating that the increased signal represented phos-
phorylation on tyrosine. This finding correlates with the
predicted activation of pp125FAK with tyrosine phos-
phorylation (Schaller et al., 1992) and with the observed
increase in phosphotyrosine on pp125FAK associated
with integrin-mediated cell adhesion (Burridge et al.,
1992b; Guan and Shalloway, 1992; Hanks, et al., 1992;
Komberg et al., 1992; Lipfert et al., 1992; Romer et al.,
1992) (Figure 6, above). Both tyrphostins AG 213 and
808 completely abrogated kinase activity (Figure 7, lanes
4 and 5), whereas herbimycin A only slightly inhibited
pp125FAK kinase activity (Figure 7, lane 3). A dose-de-
pendent inhibition of pp125FAK kinase activity by tyr-
phostin AG 213 was noted (Figure 8). This correlates
with our observations of dose-dependent inhibition of
HUVEC migration and cytoskeletal organization by
tyrphostin AG 213.
To assess the effects of tyrosine kinase inhibitors on
pp125FAK activity in intact cells, we then investigated
the activity of pp125FAK isolated from tyrosine kinase
inhibitor-treated HUVEC adhering to fibronectin (Figure
9). pp125FAK was immunoprecipitated from HUVEC
monolayers plated on fibronectin in serum-free medium.
HUVEC treated with inhibitors were pretreated with
the respective agent for 24 h before plating on fibro-
nectin. The cells were untreated (lane 1) or exposed to
1 2 345 6
Figure 8. Dose-dependent tyrphostin in-
hibition of pp125FAK kinase activity in vitro.
200 pp125FAK was immunoprecipitated from HU-VEC either kept in suspension for 1 h (lane
1) or plated for 1 h on fibronectin in serum-
116 free medium (lanes 2-6). Immunoprecipitateswere untreated (lanes 1 and 2) or treated with
97 increasing concentrations of tyrphostin AG
68 213 in the presence of 32P-labeled yATP. The
tyrphostin concentrations used were 25 ,M
(lane 3), 50 MAM (lane 4), 75 MM (lane 5), and
45 * 100 MM (lane 6). Molecular masses of marker
proteins are indicated at the left of the au-
toradiograph.
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Figure 9. Inhibition of ppl25FA" kinase activity
in HUVEC. Autophosphorylation of pp125FAi
immunoprecipitated from lysates of HUVEC
plated in serum-free medium for 1 h on fibro- 205
nectin was examined using 32P-labeled yATP.
This autoradiograph depicts the activity of
pp125F" immunoprecipitated from untreated
11
_
HUVEC (lane 1), and HUVEC treated with her- 976
bimycin A (875 nM, lane 2), tyrphostin AG 213 68
(100 iM, lane 3), or tyrphostin AG 808 (100 uM,
lane 4). All of the treated groups were pretreated 45
with the respective inhibitor for 24 h and then
plated in its presence. Molecular masses of marker
proteins are indicated at the left of the autora-
diograph.
herbimycin A (875 nM, lane 2), tyrphostin AG 213 (100
,uM, lane 3), or tyrphostin AG 808 (100 ,uM, lane 4).
Treatment with each of these tyrosine kinase inhibitors
resulted in diminished autophosphorylation of pp125F"
as compared to that of pp125FAK from untreated HUVEC
controls.
The reversibility of the tyrphostin inhibition of
pp125FAK kinase activity in HUVEC was investigated
(Figure 10). HUVEC were incubated with AG 213 (100
jiM) for 24 h, and the cells were then incubated in the
absence of the inhibitor for various time intervals before
replating on fibronectin in inhibitor-free conditions. Ki-
nase activity was assayed in pp125FAK immunoprecip-
itates from cells incubated for 12- and 24-h tyrphostin-
free intervals after treatment (Figure 10, lanes 3 and 4),
as well as from untreated HUVEC (Figure 10, lane 1),
and from HUVEC that were preincubated with and
plated in the presence of AG 213 without a tyrphostin-
free interval (Figure 10, lane 2). The diminished
pp125FAK kinase activity associated with tyrphostin AG
213 treatment was noted to return to approximately
baseline levels after a 12-h tyrphostin-free incubation
(Figure 10, lane 3). Shorter inhibitor-free incubations
were associated with incomplete recovery of pp125F"K
kinase activity possibly indicating a prolonged time for
the inhibitor to exit the cells. Recovery of cell migration
and stress fiber assembly were also studied in tyrphos-
tin-treated HUVEC that were incubated in tyrphostin-
free conditions for 18 h. Migration was normal in HU-
VEC monolayers wounded after this tyrphostin-free
interval. Similarly, cytoskeletal assembly was normal in
HUVEC plated on fibronectin after the same time in-
terval without tyrphostin.
DISCUSSION
We have used two different model systems to study
endothelial cell interactions with extracellular matrix.
Both in cells migrating into wounds and in cells freshly
plated on fibronectin, we observed increased tyrosine
phosphorylation in focal adhesions. Immunoblots of
HUVEC lysates revealed a prominent phosphotyrosine-
containing band at 120-130 kDa that was increased in
migrating cells. One of the proteins in this cluster is
pp125FAK, which exhibits increased kinase activity in
HUVEC migrating into wounds. This finding is consis-
tent with other published observations, including the
description of pp125FAK as a focal adhesion constituent
in fibroblasts (Hanks et al., 1992; Schaller et al., 1992),
and the activation of pp125FAK kinase activity during
integrin-mediated cell adhesion (Guan and Shalloway,
1992). Our finding that HUVEC required a 7-d incu-
bation without exposure to fresh serum and growth
factors to achieve a quiescent state is consistent with
others' experience with the induction of quiescence in
Swiss 3T3 cells (Rozengurt and Sinnett-Smith, 1983)
and with the level of pp125F" tyrosine phosphorylation
in those cells (Zachary et al., 1992). Recent insights from
digitized real time imaging of focal adhesions in con-
fluent endothelial cell monolayers indicate that remod-
eling of these structures may occur in quiescent cells
(Davies et al., 1993). This dynamic state of focal adhe-
sions could account for the low level of pp125FAK kinase
activity that persists in intact HUVEC monolayers, as
seen in Figure 2C, lane 1. Additional focal adhesion
proteins become tyrosine phosphorylated during en-
dothelial cell adhesion to extracellular matrix. For ex-
ample, we have also detected elevated phosphotyrosine
in paxillin immunoprecipitated from HUVEC that were
freshly plated and forming new focal adhesions
on fibronectin (Romer, unpublished data). The fact
that a band corresponding to paxillin is not seen in









Figure 10. Recovery of pp125F" kinase activity after tyrphostin
treatment. HUVEC were plated on fibronectin for 1 h in serum-free
medium in the absence (lanes 1, 3, and 4) or presence (lane 2) of
tyrphostin AG 213 (100 MM). HUVEC for the samples in lane 2 were
preincubated with tyrphostin AG 213 for 24 h before plating. Twelve-
and 24-h inhibitor-free recovery periods (after AG 213 pretreatment)
were used for HUVEC in lanes 3 and 4 respectively. pp125FAK was
then immunoprecipitated from lysates of these cells and assayed for
kinase activity by autophosphorylation with 32P-labeled -yATP. Re-
covery of activity is seen in the pp125F" from HUVEC plated after
a tyrphostin-free interval of 12 or more hours. Molecular masses of
marker proteins are indicated at the left of the autoradiograph.
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We have also demonstrated that certain tyrosine ki-
nase inhibitors prevented the tyrosine phosphorylation
of pp125FAK and interfered with its kinase activity at
concentrations that inhibited the cytoskeletal organi-
zation and motility of HUVEC. These observations sug-
gest that the activation of this focal adhesion kinase
may be necessary for the cytoskeletal organization ac-
companying HUVEC spreading and migration. Thus,
in the absence of elevated levels of pp125FAK activity,
there would be insufficient formation of focal adhesions
to support cell migration. This scenario is consonant
with the role of pp125FAK that is being defined in the
work of other investigators. Thus, the tyrosine phos-
phorylation of pp125FAK has been implicated as an im-
portant event in cell spreading (Pelletier et al., 1992),
in cytoskeletal organization during cell adhesion (Bur-
ridge et al., 1992b; Romer et al., 1992), and in the cyto-
skeletal organization that accompanies cytokine-stim-
ulated neutrophil adhesion to fibrinogen (Fuortes et al.,
1993). Recent studies have also correlated increased
levels of pp125FAK expression with neoplasia and me-
tastasis in human colon and breast epithelial cancers in
vivo (Weiner et al., 1993). These data suggest that
pp125FAK may have a role in the behavior and inva-
siveness of tumor cells.
Our data from the use of specific tyrosine kinase in-
hibitors with two different mechanisms of action suggest
that it is the inhibition of tyrosine kinase activity, rather
than any other effect of these agents, that is responsible
for the reported observations. In addition, the use of
these two different classes of inhibitors may assist in
probing the series of events leading to pp125FAK acti-
vation. Tyrphostins are competitive inhibitors of tyro-
sine kinases that have been engineered to mimic the
structure of a tyrosine residue in a peptide chain (Lev-
itski, 1990). They do not affect the activity of protein
kinase A, protein kinase C, serine kinases, or threonine
kinases (Levitski, 1990; Dvir et al., 1991). Tyrphostins
have been noted to inhibit the induction of pp125FAK
tyrosine phosphorylation by neuropeptides (Seckl and
Rozengurt, 1993). The benzoquinonoid ansamycin her-
bimycin A, however, is an inhibitor of Src-family kinases
with a complex mechanism of action, involving the
transfer of a sulfhydryl group (Uehara et al., 1989). We
note that these two types of inhibitors also have de-
monstrably different effects on pp125F-K kinase activity.
The complete abrogation of pp125FAK autophosphory-
lation by tyrphostin AG 213 or AG 808 treatment of
isolated pp125F' immunoprecipitates contrasts sharply
with the slight inhibition associated with herbimycin A
treatment (Figure 7). Tyrphostin and herbimycin A
treatment have much more comparable effects on
pp125FAK kinase activity when the inhibitors are used
on whole cells (Figure 9). This may indicate that her-
bimycin A inhibits another kinase that phosphorylates
and activates pp125FAK after integrin occupancy in the
intact cell. Alternatively, the incomplete action of her-
bimycin A in isolated enzyme systems in vitro may in-
dicate that the inhibitor must undergo some metabolism
by the cell to become completely active. This latter ex-
planation is consistent with the incomplete inhibition
of pp6Osrc activity by herbimycin A that is observed in
immunoprecipitation kinase assays (Uehara et al., 1986).
Our findings that tyrosine kinase inhibitors interfere
with cytoskeletal organization contrast with the findings
of improved cell spreading and stress fiber formation
seen with the use of similar agents on Rous sarcoma
virus-transformed rat kidney cells (Uehara et al., 1985).
The different effects of tyrosine kinase inhibitors in
transformed and normal cells may be explained by the
very different levels of tyrosine kinase activity in the
two populations. The abnormally high and unregulated
expression of pp6ov-src in these transformed cells may
interfere with orderly protein interactions and specific
sequences of tyrosine phosphorylation events that are
essential for normal cytoskeletal assembly. Recent work
on modulation of tyrosine phosphatase activity in v-
src-transfected NIH 3T3 cells supports this view
(Woodford-Thomas et al., 1992). Increased phosphatase
expression and decreased pp6ov-src kinase activity in this
system was associated with more normal cytoskeletal
organization and cell morphology. In the nontrans-
formed human vascular endothelial cells studied here,
treatment with tyrosine kinase inhibitors was likely suf-
ficient to abolish the essential levels of kinase activity
needed for normal cytoskeletal function.
Our observation that migrating endothelial cells ex-
hibit well formed focal adhesions differs from descrip-
tions of focal adhesions as typical features of a station-
ary, well spread phenotype (Couchman and Rees, 1979;
Kolega et al., 1982). The contrast in these results may
reflect differences in cell type and extracellular matrix
environment, but we suspect that this difference is
mostly attributable to the techniques used to image focal
adhesions. The earlier studies used the definition of a
focal adhesion as a structure appearing black or dark
gray by interference reflection microscopy, indicating a
separation of 10-15 nm between the cell surface and
the substratum. Focal adhesions are more frequently
defined by immunofluorescence, using antibodies
against constituent proteins that label focal adhesion
components (Burridge et al., 1988). These two tech-
niques usually coincide in the identification of focal
adhesions. We have noted, however, that in cells freshly
plated on extracellular matrix proteins focal adhesions
are sometimes detected by antibody staining but not by
interference reflection microscopy, indicating that the
separation between the cell surface and substratum at
these sites is greater than -15 nm (Burridge, unpub-
lished data). Similarly, fibroblasts migrating on laminin
revealed focal adhesions upon examination with im-
munofluorescence but did not exhibit the characteristic
black plaques by interference reflection microscopy
(Regen and Horwitz, 1992). These investigators also
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demonstrated the dynamic turnover of focal adhesion
constituents in migrating fibroblasts (Regen and Hor-
witz, 1992). It is noteworthy that immobilization of the
focal adhesion protein talin in fibroblasts by microin-
jection of specific antibodies resulted in the inhibition
of both focal adhesion formation and cell migration
(Nuckolls et al., 1992). A similar result was found in
this study, in which tyrosine kinase inhibitors blocked
both focal adhesion formation and HUVEC migration.
Many processes affect or participate in endothelial
cell migration, including growth factors, proteolytic en-
zymes, chemotactic peptides, and inflammatory cyto-
kines. It will be important to determine the relationship
of pp125FAK to these agents. Insulin-like growth factor
1, platelet-derived growth factor (via ,B receptors), basic
fibroblast growth factor, and scatter factor (hepatocyte
growth factor) all stimulate endothelial cell migratory
responses (Bussolino et al., 1992; Eriksson et al., 1992;
Nakao-Hayashi et al., 1992; Pepper et al., 1992). Many
of the cellular effects of these growth factors are me-
diated by receptor-type tyrosine kinases. Interactions of
the tyrosine kinase inhibitors used in this current work
with receptor kinases will need to be investigated. In-
flammatory cytokines, including interleukins 1, 6, and
8, tumor necrosis factor-a, and transforming growth
factor-d, have been demonstrated to increase endothe-
lial cell motility (Pepper et al., 1990; Yang and Moses,
1990; Rosen et al., 1991; Basson et al., 1992; Koch et al.,
1992). Some of these proteins also alter the repertoire
of HUVEC integrin expression (Defillipi et al., 1992)
and rearrange HUVEC cytoskeletal structures (Molony
and Armstrong, 1991). Cytokines that impact upon en-
dothelial cell motility through the alteration of integrmn-
mediated adhesiveness may also affect pp125FAK
activity.
The mechanism by which integrin receptor occupancy
is coupled to the adhesion-associated tyrosine phos-
phorylation of pp125FAK remains unknown. A 20-min
interval of intracellular calcium oscillations has been
noted to precede cell spreading and tyrosine phos-
phorylation during adhesion to fibrinogen in human
293 cells transfected with cDNA for the integrin aIIb#3
(Pelletier et al., 1992). Inhibition of these oscillations
was found to prevent tyrosine phosphorylation of a 125-
kDa protein (presumably pp125 AK), suggesting that
pp125FAK phosphorylation may follow the ionic events
(Pelletier et al., 1992). Recent HUVEC data indicate that
spreading on fibronectin is also associated with an in-
crease in intracellular calcium (Schwartz, 1993). It is
possible that integrin occupancy may activate other ty-
rosine kinases that are upstream of pp125FAK in this
signaling pathway. The coprecipitation of an -58 kDa
phosphoprotein with pp125FAK in our Figures 7, 9, and
10 invites speculation that a tyrosine kinase of the Src
family may be associated with pp125FAK and may par-
ticipate in the sequence of tyrosine phosphorylation
events during cell adhesion. This speculation is sup-
ported by recent studies that demonstrate stable com-
plexes of pp125FAK with pp6O,-src and pp59fyn (Xing et
al., 1993; Cobb et al., 1994). Our current data support
but do not prove the hypothesis that pp125FAK has a
role in cytoskeletal organization and migration in the
endothelium. Other tyrosine kinases may also be in-
volved and are under investigation. The development
of more specific tyrosine kinase inhibitors may help
elucidate the complex series of tyrosine phosphorylation
events that accompanies cell adhesion to extracellular
matrix proteins.
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